You are here

Article Text

Article menu
Download PDFPDF
Letter
Varicella vaccination for HIV-infected children
  1. A Knorr1,
  2. E Hutchison2,
  3. A Finn3
  1. 1
    Paediatric Department, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
  2. 2
    Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
  3. 3
    Institute of Child Life & Health, Bristol, UK
  1. Professor Adam Finn, Institute of Child Life & Health, Level 6, UBHT Education Centre, Upper Maudlin Street, Bristol BS2 8AE, UK; Adam.Finn{at}bristol.ac.uk

https://doi.org/10.1136/adc.2008.144451

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Human immunodeficiency virus (HIV)-infected children are more likely to develop severe varicella and to die when infected than otherwise healthy children.1 2 In the absence of universal immunisation varicella remains prevalent.3 Secondary prophylaxis in exposed high-risk patients is expensive, invasive, carries the risk of side-effects and may not be implemented reliably. Primary prophylaxis with live-attenuated varicella vaccine has been shown to be safe and immunogenic and effective against both primary varicella and zoster recurrences in HIV-infected children …

    View Full Text

    Footnotes

    • Competing interests: AF undertakes clinical research and has spoken at meetings sponsored by vaccine manufacturers who make varicella vaccines and has also done advisory work for them. He has not received any personal payments for this work.